Lgals3 | Mouse | (+)-schisandrin B | multiple interactions | ISO | Lgals3 (Rattus norvegicus) | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LGALS3 mRNA] | CTD | PMID:31150632 |
Lgals3 | Mouse | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LGALS3 mRNA | CTD | PMID:36331819 |
Lgals3 | Mouse | 1,1-dichloroethene | increases expression | EXP | | 6480464 | vinylidene chloride results in increased expression of LGALS3 mRNA | CTD | PMID:26682919 |
Lgals3 | Mouse | 1,4-dichlorobenzene | increases expression | EXP | | 6480464 | 4-dichlorobenzene results in increased expression of LGALS3 mRNA | CTD | PMID:26975756 |
Lgals3 | Mouse | 1-naphthyl isothiocyanate | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | 1-Naphthylisothiocyanate results in increased expression of LGALS3 mRNA | CTD | PMID:17522070 more ... |
Lgals3 | Mouse | 17alpha-ethynylestradiol | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Ethinyl Estradiol results in increased expression of LGALS3 mRNA | CTD | PMID:17557909 |
Lgals3 | Mouse | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of LGALS3 mRNA | CTD | PMID:15598610 |
Lgals3 | Mouse | 17beta-estradiol | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA and [Estradiol co-treated with Progesterone] results in decreased expression of LGALS3 mRNA | CTD | PMID:20660070 and PMID:20823114 |
Lgals3 | Mouse | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of LGALS3 mRNA | CTD | PMID:15289156 |
Lgals3 | Mouse | 2,2',4,4'-Tetrabromodiphenyl ether | multiple interactions | EXP | | 6480464 | [Flame Retardants results in increased abundance of 2 more ... | CTD | PMID:38995820 |
Lgals3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of LGALS3 mRNA | CTD | PMID:20159946 |
Lgals3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA | CTD | PMID:17035482 more ... |
Lgals3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA | CTD | PMID:11489354 more ... |
Lgals3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of LGALS3 mRNA | CTD | PMID:21570461 more ... |
Lgals3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of LGALS3 mRNA | CTD | PMID:20959002 more ... |
Lgals3 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of LGALS3 mRNA | CTD | PMID:22298810 and PMID:34747641 |
Lgals3 | Mouse | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:26705709 |
Lgals3 | Mouse | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:38648751 |
Lgals3 | Mouse | 2,6-dimethoxyphenol | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [Sodium Chloride co-treated with pyrogallol 1 and 3-dimethyl ether] results in increased expression of and affects the localization of LGALS3 protein | CTD | PMID:38598786 |
Lgals3 | Mouse | 2-hydroxypropanoic acid | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of LGALS3 mRNA | CTD | PMID:30851411 |
Lgals3 | Mouse | 2-nitrofluorene | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | 2-nitrofluorene results in increased expression of LGALS3 mRNA | CTD | PMID:15890375 |
Lgals3 | Mouse | 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:20959002 |
Lgals3 | Mouse | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:23196670 |
Lgals3 | Mouse | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | tetrabromobisphenol A results in decreased expression of LGALS3 protein | CTD | PMID:31675489 |
Lgals3 | Mouse | 3-chloropropane-1,2-diol | decreases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in decreased expression of LGALS3 mRNA | CTD | PMID:28522335 |
Lgals3 | Mouse | 3-chloropropane-1,2-diol | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | alpha-Chlorohydrin results in increased expression of LGALS3 protein | CTD | PMID:34915118 |
Lgals3 | Mouse | 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of LGALS3 mRNA | CTD | PMID:20713471 |
Lgals3 | Mouse | 3H-1,2-dithiole-3-thione | decreases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | 1 and 2-dithiol-3-thione results in decreased expression of LGALS3 mRNA | CTD | PMID:19162173 |
Lgals3 | Mouse | 4,4'-diaminodiphenylmethane | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in increased expression of LGALS3 mRNA | CTD | PMID:25380136 |
Lgals3 | Mouse | 4,4'-sulfonyldiphenol | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | bisphenol S results in decreased expression of LGALS3 mRNA | CTD | PMID:25912373 |
Lgals3 | Mouse | 4,4'-sulfonyldiphenol | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of LGALS3 protein | CTD | PMID:34186270 |
Lgals3 | Mouse | 4,4'-sulfonyldiphenol | decreases methylation | EXP | | 6480464 | bisphenol S results in decreased methylation of LGALS3 exon | CTD | PMID:33297965 |
Lgals3 | Mouse | 4,4'-sulfonyldiphenol | decreases expression | EXP | | 6480464 | bisphenol S results in decreased expression of LGALS3 mRNA | CTD | PMID:39298647 |
Lgals3 | Mouse | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of LGALS3 mRNA | CTD | PMID:30951980 |
Lgals3 | Mouse | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of LGALS3 mRNA | CTD | PMID:15890375 |
Lgals3 | Mouse | 4-hydroxyphenyl retinamide | decreases expression | EXP | | 6480464 | Fenretinide results in decreased expression of LGALS3 mRNA | CTD | PMID:28973697 |
Lgals3 | Mouse | 5-aza-2'-deoxycytidine | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Decitabine results in increased expression of LGALS3 mRNA | CTD | PMID:19194470 |
Lgals3 | Mouse | 5-fluorouracil | affects response to substance | ISO | LGALS3 (Homo sapiens) | 6480464 | LGALS3 protein affects the susceptibility to Fluorouracil | CTD | PMID:16217747 |
Lgals3 | Mouse | 5-fluorouracil | multiple interactions | ISO | Lgals3 (Rattus norvegicus) | 150530464 | 5-fluorouracil inhibits the reaction [N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum] | RGD | |
Lgals3 | Mouse | 5-fluorouracil | decreases response to substance | ISO | LGALS3 (Homo sapiens) | 6480464 | LGALS3 protein mutant form results in decreased susceptibility to Fluorouracil | CTD | PMID:21750908 |
Lgals3 | Mouse | 6-propyl-2-thiouracil | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of LGALS3 mRNA | CTD | PMID:24780913 |
Lgals3 | Mouse | 7,12-dimethyltetraphene | affects expression | EXP | | 6480464 | 9 more ... | CTD | PMID:21785161 |
Lgals3 | Mouse | acetamide | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of LGALS3 mRNA | CTD | PMID:31881176 |
Lgals3 | Mouse | actinomycin D | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of LGALS3 protein and Dactinomycin inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] | CTD | PMID:21821001 and PMID:38460933 |
Lgals3 | Mouse | aflatoxin B1 | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Aflatoxin B1 results in increased expression of LGALS3 mRNA | CTD | PMID:15890375 |
Lgals3 | Mouse | aflatoxin B1 | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of LGALS3 mRNA | CTD | PMID:27153756 |
Lgals3 | Mouse | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of LGALS3 mRNA | CTD | PMID:19770486 |
Lgals3 | Mouse | all-trans-retinoic acid | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of LGALS3 mRNA | CTD | PMID:12875902 |
Lgals3 | Mouse | all-trans-retinoic acid | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of LGALS3 mRNA | CTD | PMID:23724009 |
Lgals3 | Mouse | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of LGALS3 mRNA | CTD | PMID:16604517 |
Lgals3 | Mouse | ammonium chloride | affects expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of LGALS3 mRNA | CTD | PMID:16483693 |
Lgals3 | Mouse | amphetamine | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Amphetamine results in increased expression of LGALS3 mRNA | CTD | PMID:30779732 |
Lgals3 | Mouse | aristolochic acid A | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of LGALS3 protein | CTD | PMID:33212167 |
Lgals3 | Mouse | arsenite(3-) | decreases expression | EXP | | 6480464 | arsenite results in decreased expression of LGALS3 protein | CTD | PMID:37955338 |
Lgals3 | Mouse | arsenite(3-) | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to LGALS3 protein] and arsenite promotes the reaction [G3BP1 protein binds to LGALS3 mRNA] | CTD | PMID:32406909 |
Lgals3 | Mouse | arsenous acid | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of LGALS3 mRNA | CTD | PMID:20458559 |
Lgals3 | Mouse | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of LGALS3 mRNA | CTD | PMID:22228805 and PMID:23735875 |
Lgals3 | Mouse | benzo[a]pyrene | increases methylation | ISO | LGALS3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of LGALS3 5' UTR | CTD | PMID:27901495 |
Lgals3 | Mouse | benzo[a]pyrene | affects methylation | ISO | LGALS3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of LGALS3 promoter | CTD | PMID:27901495 |
Lgals3 | Mouse | benzo[a]pyrene | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of LGALS3 mRNA and Benzo(a)pyrene results in increased expression of LGALS3 protein | CTD | PMID:16269432 more ... |
Lgals3 | Mouse | benzo[b]fluoranthene | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | benzo(b)fluoranthene results in increased expression of LGALS3 mRNA | CTD | PMID:16269432 |
Lgals3 | Mouse | beta-lapachone | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of LGALS3 mRNA | CTD | PMID:38218311 |
Lgals3 | Mouse | beta-naphthoflavone | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in increased expression of LGALS3 mRNA | CTD | PMID:19737606 |
Lgals3 | Mouse | bexarotene | decreases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | bexarotene results in decreased expression of LGALS3 mRNA | CTD | PMID:16648578 |
Lgals3 | Mouse | bezafibrate | increases expression | EXP | | 6480464 | Bezafibrate results in increased expression of LGALS3 mRNA | CTD | PMID:17118139 |
Lgals3 | Mouse | bis(2-chloroethyl) sulfide | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Mustard Gas results in increased expression of LGALS3 protein | CTD | PMID:33002157 |
Lgals3 | Mouse | bis(2-ethylhexyl) phthalate | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of LGALS3 mRNA | CTD | PMID:31163220 |
Lgals3 | Mouse | bisphenol A | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of LGALS3 mRNA | CTD | PMID:25181051 |
Lgals3 | Mouse | bisphenol A | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of LGALS3 protein | CTD | PMID:34186270 |
Lgals3 | Mouse | bisphenol A | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of LGALS3 protein | CTD | PMID:33376534 and PMID:37567409 |
Lgals3 | Mouse | bisphenol A | affects expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of LGALS3 mRNA | CTD | PMID:32145629 |
Lgals3 | Mouse | bisphenol A | affects expression | ISO | LGALS3 (Homo sapiens) | 6480464 | bisphenol A affects the expression of LGALS3 mRNA | CTD | PMID:30903817 |
Lgals3 | Mouse | bisphenol A | increases methylation | ISO | Lgals3 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of LGALS3 gene | CTD | PMID:28505145 |
Lgals3 | Mouse | bisphenol AF | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of LGALS3 protein | CTD | PMID:34186270 |
Lgals3 | Mouse | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of LGALS3 mRNA | CTD | PMID:30951980 |
Lgals3 | Mouse | bleomycin A2 | multiple interactions | EXP | | 6480464 | NOS2 protein affects the reaction [Bleomycin results in increased expression of LGALS3 protein] | CTD | PMID:26526764 |
Lgals3 | Mouse | bleomycin A2 | increases expression | EXP | | 6480464 | Bleomycin results in increased expression of LGALS3 protein | CTD | PMID:26526764 |
Lgals3 | Mouse | bucladesine | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA | CTD | PMID:20823114 |
Lgals3 | Mouse | buspirone | decreases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Buspirone results in decreased expression of LGALS3 mRNA | CTD | PMID:24136188 |
Lgals3 | Mouse | cadmium dichloride | affects expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Cadmium Chloride affects the expression of LGALS3 mRNA | CTD | PMID:22110744 |
Lgals3 | Mouse | cadmium dichloride | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Cadmium Chloride results in increased expression of LGALS3 mRNA | CTD | PMID:25993096 |
Lgals3 | Mouse | calcitriol | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of LGALS3 mRNA | CTD | PMID:12875902 |
Lgals3 | Mouse | calyculin a | increases expression | EXP | | 6480464 | calyculin A results in increased expression of LGALS3 mRNA | CTD | PMID:25270620 |
Lgals3 | Mouse | carbon nanotube | affects expression | EXP | | 6480464 | Nanotubes and Carbon affects the expression of LGALS3 mRNA | CTD | PMID:23845593 |
Lgals3 | Mouse | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25554681 and PMID:27106021 |
Lgals3 | Mouse | cefaloridine | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Cephaloridine results in increased expression of LGALS3 mRNA | CTD | PMID:18500788 |
Lgals3 | Mouse | CGP 52608 | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to LGALS3 gene] | CTD | PMID:28238834 |
Lgals3 | Mouse | chloroform | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Chloroform results in increased expression of LGALS3 mRNA | CTD | PMID:17522070 |
Lgals3 | Mouse | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA | CTD | PMID:20938992 |
Lgals3 | Mouse | ciglitazone | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [ciglitazone binds to PPARG protein] which results in increased expression of LGALS3 mRNA | CTD | PMID:16197558 |
Lgals3 | Mouse | cisplatin | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | 4-benzyl-2-methyl-1 more ... | CTD | PMID:21368866 and PMID:21821001 |
Lgals3 | Mouse | cisplatin | multiple interactions | ISO | Lgals3 (Rattus norvegicus) | 6480464 | [citrus pectin co-treated with Cisplatin] results in increased localization of LGALS3 protein | CTD | PMID:38522819 |
Lgals3 | Mouse | cisplatin | decreases response to substance | ISO | LGALS3 (Homo sapiens) | 6480464 | GAL3 protein results in decreased susceptibility to Cisplatin more ... | CTD | PMID:21368866 more ... |
Lgals3 | Mouse | cisplatin | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of LGALS3 mRNA and Cisplatin results in increased expression of LGALS3 protein | CTD | PMID:21821001 and PMID:27392435 |
Lgals3 | Mouse | clofibrate | increases expression | EXP | | 6480464 | Clofibrate results in increased expression of LGALS3 mRNA | CTD | PMID:17585979 |
Lgals3 | Mouse | cobalt dichloride | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | cobaltous chloride results in increased expression of LGALS3 mRNA | CTD | PMID:24386269 |
Lgals3 | Mouse | copper(II) sulfate | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of LGALS3 mRNA | CTD | PMID:19549813 |
Lgals3 | Mouse | Cuprizon | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of LGALS3 mRNA | CTD | PMID:26577399 and PMID:27523638 |
Lgals3 | Mouse | cycloheximide | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | Cycloheximide inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of LGALS3 protein] | CTD | PMID:21821001 |
Lgals3 | Mouse | cyclosporin A | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of LGALS3 mRNA | CTD | PMID:25562108 and PMID:27989131 |
Lgals3 | Mouse | decabromodiphenyl ether | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | decabromobiphenyl ether results in decreased expression of LGALS3 protein | CTD | PMID:31675489 |
Lgals3 | Mouse | dexamethasone | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [GCS-100 co-treated with Dexamethasone] results in decreased expression of LGALS3 protein | CTD | PMID:16166312 |
Lgals3 | Mouse | dexamethasone | decreases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Dexamethasone results in decreased expression of LGALS3 mRNA | CTD | PMID:17522070 |
Lgals3 | Mouse | diarsenic trioxide | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Arsenic Trioxide results in increased expression of LGALS3 mRNA | CTD | PMID:20458559 |
Lgals3 | Mouse | dibenz[a,h]anthracene | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | 1 more ... | CTD | PMID:16269432 |
Lgals3 | Mouse | dibenzo[a,l]pyrene | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | dibenzo(a and l)pyrene results in increased expression of LGALS3 protein | CTD | PMID:18495319 |
Lgals3 | Mouse | Dibutyl phosphate | affects expression | ISO | LGALS3 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of LGALS3 mRNA | CTD | PMID:37042841 |
Lgals3 | Mouse | diclofenac | increases expression | EXP | | 6480464 | Diclofenac results in increased expression of LGALS3 mRNA | CTD | PMID:26934552 |
Lgals3 | Mouse | dicrotophos | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of LGALS3 mRNA | CTD | PMID:28302478 |
Lgals3 | Mouse | diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of LGALS3 mRNA | CTD | PMID:15289156 |
Lgals3 | Mouse | diethylstilbestrol | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Diethylstilbestrol results in increased expression of LGALS3 mRNA | CTD | PMID:15890375 |
Lgals3 | Mouse | dimethylarsinic acid | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Cacodylic Acid results in increased expression of LGALS3 mRNA | CTD | PMID:16122865 |
Lgals3 | Mouse | dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of LGALS3 mRNA | CTD | PMID:17193925 |
Lgals3 | Mouse | dioxygen | multiple interactions | EXP | | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of LGALS3 mRNA and [Oxygen deficiency co-treated with Blood Glucose deficiency] results in increased expression of LGALS3 mRNA | CTD | PMID:19640911 and PMID:30529165 |
Lgals3 | Mouse | dioxygen | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Oxygen deficiency results in increased expression of LGALS3 protein and Oxygen results in increased expression of LGALS3 mRNA | CTD | PMID:22911455 and PMID:32003113 |
Lgals3 | Mouse | diquat | increases expression | EXP | | 6480464 | Diquat results in increased expression of LGALS3 mRNA | CTD | PMID:36851058 |
Lgals3 | Mouse | diuron | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Diuron results in increased expression of LGALS3 mRNA | CTD | PMID:21551480 |
Lgals3 | Mouse | dorsomorphin | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 |
Lgals3 | Mouse | doxorubicin | decreases response to substance | ISO | LGALS3 (Homo sapiens) | 6480464 | LGALS3 mRNA results in decreased susceptibility to Doxorubicin | CTD | PMID:16322897 |
Lgals3 | Mouse | doxorubicin | increases expression | EXP | | 6480464 | Doxorubicin results in increased expression of LGALS3 mRNA | CTD | PMID:36227756 |
Lgals3 | Mouse | doxorubicin | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of LGALS3 mRNA | CTD | PMID:29803840 |
Lgals3 | Mouse | endosulfan | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Endosulfan results in increased expression of LGALS3 mRNA | CTD | PMID:29391264 |
Lgals3 | Mouse | entinostat | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | entinostat results in increased expression of LGALS3 mRNA | CTD | PMID:26272509 |
Lgals3 | Mouse | entinostat | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA | CTD | PMID:27188386 |
Lgals3 | Mouse | erythromycin estolate | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Erythromycin Estolate results in increased expression of LGALS3 mRNA | CTD | PMID:17522070 |
Lgals3 | Mouse | etoposide | affects response to substance | ISO | LGALS3 (Homo sapiens) | 6480464 | LGALS3 protein affects the susceptibility to Etoposide | CTD | PMID:16217747 |
Lgals3 | Mouse | fenamidone | increases expression | EXP | | 6480464 | fenamidone results in increased expression of LGALS3 mRNA | CTD | PMID:27029645 |
Lgals3 | Mouse | ferric oxide | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | ferric oxide analog results in increased expression of LGALS3 mRNA | CTD | PMID:38615722 |
Lgals3 | Mouse | flurbiprofen | increases expression | EXP | | 6480464 | Flurbiprofen results in increased expression of LGALS3 mRNA | CTD | PMID:16949054 |
Lgals3 | Mouse | folic acid | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Folic Acid results in increased expression of LGALS3 mRNA | CTD | PMID:10980121 |
Lgals3 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA | CTD | PMID:20938992 |
Lgals3 | Mouse | furfural | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of LGALS3 protein | CTD | PMID:38598786 |
Lgals3 | Mouse | genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of LGALS3 mRNA | CTD | PMID:15289156 |
Lgals3 | Mouse | gentamycin | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Gentamicins results in increased expression of LGALS3 mRNA | CTD | PMID:33387578 |
Lgals3 | Mouse | glafenine | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Glafenine results in increased expression of LGALS3 mRNA | CTD | PMID:24136188 |
Lgals3 | Mouse | isoprenaline | increases expression | EXP | | 6480464 | Isoproterenol results in increased expression of LGALS3 mRNA | CTD | PMID:20003209 |
Lgals3 | Mouse | ivermectin | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of LGALS3 protein | CTD | PMID:32959892 |
Lgals3 | Mouse | L-ascorbic acid | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Ascorbic Acid results in increased expression of LGALS3 mRNA | CTD | PMID:15372504 |
Lgals3 | Mouse | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of LGALS3 mRNA | CTD | PMID:20938992 |
Lgals3 | Mouse | lactose | affects binding | ISO | LGALS3 (Homo sapiens) | 6480464 | Lactose binds to LGALS3 protein | CTD | PMID:17385862 |
Lgals3 | Mouse | leflunomide | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | leflunomide results in increased expression of LGALS3 mRNA | CTD | PMID:28988120 and PMID:29427785 |
Lgals3 | Mouse | LY294002 | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of and affects the localization of LGALS3 protein more ... | CTD | PMID:21821001 |
Lgals3 | Mouse | LY294002 | decreases response to substance | ISO | LGALS3 (Homo sapiens) | 6480464 | LGALS3 results in decreased susceptibility to 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | CTD | PMID:21821001 |
Lgals3 | Mouse | manganese(II) chloride | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | manganese chloride results in increased expression of LGALS3 mRNA | CTD | PMID:28801915 |
Lgals3 | Mouse | medroxyprogesterone acetate | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of LGALS3 mRNA | CTD | PMID:20823114 |
Lgals3 | Mouse | mercury dibromide | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | mercuric bromide results in increased expression of LGALS3 mRNA | CTD | PMID:26272509 |
Lgals3 | Mouse | mercury dibromide | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA | CTD | PMID:27188386 |
Lgals3 | Mouse | methapyrilene | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Methapyrilene results in increased expression of LGALS3 mRNA | CTD | PMID:15890375 |
Lgals3 | Mouse | methimazole | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Methimazole results in increased expression of LGALS3 mRNA | CTD | PMID:20144635 |
Lgals3 | Mouse | methoxychlor | increases methylation | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Methoxychlor results in increased methylation of LGALS3 gene | CTD | PMID:23303685 |
Lgals3 | Mouse | methylmercury chloride | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of LGALS3 mRNA | CTD | PMID:23179753 and PMID:34089799 |
Lgals3 | Mouse | methylmercury chloride | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of LGALS3 mRNA | CTD | PMID:28001369 |
Lgals3 | Mouse | microcystin-LR | increases expression | EXP | | 6480464 | cyanoginosin LR results in increased expression of LGALS3 mRNA | CTD | PMID:17654400 |
Lgals3 | Mouse | mifepristone | decreases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Mifepristone results in decreased expression of LGALS3 mRNA | CTD | PMID:25972201 |
Lgals3 | Mouse | mitomycin C | affects response to substance | ISO | LGALS3 (Homo sapiens) | 6480464 | LGALS3 protein affects the susceptibility to Mitomycin | CTD | PMID:16217747 |
Lgals3 | Mouse | monocrotaline | multiple interactions | ISO | Lgals3 (Rattus norvegicus) | 6480464 | [Monocrotaline co-treated with LGALS3 protein] inhibits the reaction [[Monocrotaline co-treated with TGFB1] results in decreased expression of MMP9 protein] more ... | CTD | PMID:27870162 |
Lgals3 | Mouse | N,N-diethyl-m-toluamide | multiple interactions | ISO | Lgals3 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of LGALS3 gene | CTD | PMID:33148267 |
Lgals3 | Mouse | N-acetylsphingosine | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | N-acetylsphingosine results in increased expression of LGALS3 protein | CTD | PMID:21821001 |
Lgals3 | Mouse | N-acetylsphingosine | decreases response to substance | ISO | LGALS3 (Homo sapiens) | 6480464 | LGALS3 results in decreased susceptibility to N-acetylsphingosine | CTD | PMID:21821001 |
Lgals3 | Mouse | N-acetylsphingosine | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | 4-benzyl-2-methyl-1 more ... | CTD | PMID:21821001 |
Lgals3 | Mouse | N-ethyl-N-nitrosourea | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Ethylnitrosourea results in increased expression of LGALS3 mRNA | CTD | PMID:15954086 |
Lgals3 | Mouse | N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA | CTD | PMID:19840844 |
Lgals3 | Mouse | N-methyl-N-nitrosourea | decreases expression | EXP | | 6480464 | Methylnitrosourea results in decreased expression of LGALS3 mRNA | CTD | PMID:25270620 |
Lgals3 | Mouse | N-methyl-N-nitrosourea | increases expression | ISO | Lgals3 (Rattus norvegicus) | 150530464 | N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum | RGD | |
Lgals3 | Mouse | N-nitrosodiethylamine | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Diethylnitrosamine results in increased expression of LGALS3 mRNA | CTD | PMID:19638242 |
Lgals3 | Mouse | N-nitrosodiethylamine | multiple interactions | ISO | Lgals3 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3 mRNA | CTD | PMID:28943392 |
Lgals3 | Mouse | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LGALS3 mRNA | CTD | PMID:24535843 |
Lgals3 | Mouse | N-nitrosodimethylamine | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Dimethylnitrosamine results in increased expression of LGALS3 mRNA | CTD | PMID:15890375 and PMID:25380136 |
Lgals3 | Mouse | N-nitrosodimethylamine | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Dimethylnitrosamine results in increased expression of LGALS3 mRNA | CTD | PMID:17547211 |
Lgals3 | Mouse | N-nitrosomorpholine | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | N-nitrosomorpholine results in increased expression of LGALS3 mRNA | CTD | PMID:19716841 |
Lgals3 | Mouse | naloxone | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Naloxone results in increased expression of LGALS3 mRNA | CTD | PMID:17522070 |
Lgals3 | Mouse | nickel atom | increases expression | EXP | | 6480464 | Nickel results in increased expression of LGALS3 mRNA | CTD | PMID:12540486 |
Lgals3 | Mouse | nickel subsulfide | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | nickel subsulfide results in increased expression of LGALS3 mRNA | CTD | PMID:21086188 |
Lgals3 | Mouse | nickel sulfate | affects expression | EXP | | 6480464 | nickel sulfate affects the expression of LGALS3 mRNA | CTD | PMID:12718980 |
Lgals3 | Mouse | nickel sulfate | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of LGALS3 mRNA | CTD | PMID:18651567 |
Lgals3 | Mouse | niclosamide | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Niclosamide results in increased expression of LGALS3 mRNA | CTD | PMID:36318118 |
Lgals3 | Mouse | Nonylphenol | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | nonylphenol results in increased expression of LGALS3 protein | CTD | PMID:16054331 |
Lgals3 | Mouse | Nutlin-3 | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [Dactinomycin co-treated with nutlin 3] results in increased expression of LGALS3 protein | CTD | PMID:38460933 |
Lgals3 | Mouse | ochratoxin A | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | ochratoxin A results in increased expression of LGALS3 mRNA | CTD | PMID:38301995 |
Lgals3 | Mouse | oxycodone | decreases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Oxycodone results in decreased expression of LGALS3 mRNA | CTD | PMID:23439660 |
Lgals3 | Mouse | ozone | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Ozone results in increased expression of LGALS3 protein | CTD | PMID:22727909 |
Lgals3 | Mouse | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of LGALS3 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in increased expression of LGALS3 mRNA | CTD | PMID:34911549 |
Lgals3 | Mouse | panobinostat | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | panobinostat results in increased expression of LGALS3 mRNA | CTD | PMID:26272509 |
Lgals3 | Mouse | panobinostat | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA | CTD | PMID:27188386 |
Lgals3 | Mouse | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of LGALS3 mRNA | CTD | PMID:17562736 |
Lgals3 | Mouse | paracetamol | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of LGALS3 mRNA | CTD | PMID:26690555 |
Lgals3 | Mouse | paracetamol | affects response to substance | EXP | | 6480464 | LGALS3 protein affects the susceptibility to Acetaminophen | CTD | PMID:22461450 |
Lgals3 | Mouse | paracetamol | multiple interactions | EXP | | 6480464 | LGALS3 protein affects the reaction [Acetaminophen results in increased expression of CCL20 mRNA] more ... | CTD | PMID:22461450 |
Lgals3 | Mouse | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of LGALS3 mRNA and Acetaminophen results in increased expression of LGALS3 protein | CTD | PMID:22461450 and PMID:34724096 |
Lgals3 | Mouse | paraquat | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Paraquat results in increased expression of LGALS3 mRNA and Paraquat results in increased expression of LGALS3 protein | CTD | PMID:24521700 and PMID:32680482 |
Lgals3 | Mouse | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of LGALS3 mRNA | CTD | PMID:36331819 |
Lgals3 | Mouse | perfluorooctanoic acid | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in increased expression of LGALS3 protein | CTD | PMID:26879310 |
Lgals3 | Mouse | permethrin | multiple interactions | ISO | Lgals3 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] results in decreased methylation of LGALS3 gene | CTD | PMID:33148267 |
Lgals3 | Mouse | phenacetin | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Phenacetin results in increased expression of LGALS3 mRNA | CTD | PMID:17082564 and PMID:17698508 |
Lgals3 | Mouse | phenobarbital | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of LGALS3 mRNA and NR1I3 protein affects the reaction [Phenobarbital results in increased expression of LGALS3 mRNA] | CTD | PMID:19482888 and PMID:24535843 |
Lgals3 | Mouse | phenobarbital | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Phenobarbital results in increased expression of LGALS3 mRNA | CTD | PMID:19162173 |
Lgals3 | Mouse | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of LGALS3 mRNA | CTD | PMID:19482888 |
Lgals3 | Mouse | phenylhydrazine | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | phenylhydrazine results in increased expression of LGALS3 mRNA | CTD | PMID:17082564 and PMID:17698508 |
Lgals3 | Mouse | phenylmercury acetate | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of LGALS3 mRNA | CTD | PMID:26272509 |
Lgals3 | Mouse | phenylmercury acetate | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA | CTD | PMID:27188386 |
Lgals3 | Mouse | phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | [Methylnitronitrosoguanidine co-treated with Tetradecanoylphorbol Acetate] results in increased expression of LGALS3 mRNA | CTD | PMID:19840844 |
Lgals3 | Mouse | phosgene | affects expression | EXP | | 6480464 | Phosgene affects the expression of LGALS3 mRNA | CTD | PMID:16300373 |
Lgals3 | Mouse | piperonyl butoxide | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Piperonyl Butoxide results in increased expression of LGALS3 mRNA | CTD | PMID:15890375 |
Lgals3 | Mouse | pirinixic acid | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of LGALS3 mRNA | CTD | PMID:19710929 |
Lgals3 | Mouse | pirinixic acid | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | pirinixic acid results in increased expression of LGALS3 mRNA | CTD | PMID:15890375 |
Lgals3 | Mouse | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of LGALS3 mRNA | CTD | PMID:17118139 |
Lgals3 | Mouse | potassium dichromate | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Potassium Dichromate results in increased expression of LGALS3 protein | CTD | PMID:23718831 |
Lgals3 | Mouse | progesterone | affects metabolic processing | EXP | | 6480464 | LGALS3 protein affects the metabolism of Progesterone | CTD | PMID:17242467 |
Lgals3 | Mouse | progesterone | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in decreased expression of LGALS3 mRNA | CTD | PMID:20660070 |
Lgals3 | Mouse | quercetin | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Quercetin results in increased expression of LGALS3 mRNA | CTD | PMID:21632981 |
Lgals3 | Mouse | quercetin | multiple interactions | ISO | Lgals3 (Rattus norvegicus) | 150530464 | Quercetin inhibits the reaction [N-methyl-N-nitrosourea increases expression of Lgals3 protein in serum] | RGD | |
Lgals3 | Mouse | quinolin-8-ol | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Oxyquinoline results in decreased expression of LGALS3 mRNA | CTD | PMID:21632981 |
Lgals3 | Mouse | quinoline | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | quinoline analog results in increased expression of LGALS3 protein | CTD | PMID:18645022 |
Lgals3 | Mouse | rac-lactic acid | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of LGALS3 mRNA | CTD | PMID:30851411 |
Lgals3 | Mouse | reactive oxygen species | increases abundance | ISO | LGALS3 (Homo sapiens) | 6480464 | LGALS3 protein results in increased abundance of Reactive Oxygen Species | CTD | PMID:34894372 |
Lgals3 | Mouse | resveratrol | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | resveratrol results in increased expression of LGALS3 mRNA | CTD | PMID:25905778 |
Lgals3 | Mouse | resveratrol | multiple interactions | ISO | Lgals3 (Rattus norvegicus) | 6480464 | [resveratrol co-treated with Streptozocin] results in increased expression of LGALS3 mRNA | CTD | PMID:25905778 |
Lgals3 | Mouse | rotenone | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Rotenone results in increased expression of LGALS3 mRNA | CTD | PMID:27900601 |
Lgals3 | Mouse | S-(1,2-dichlorovinyl)-L-cysteine | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | S-(1 and 2-dichlorovinyl)cysteine results in decreased expression of LGALS3 mRNA | CTD | PMID:36336211 and PMID:37544576 |
Lgals3 | Mouse | SB 431542 | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 |
Lgals3 | Mouse | silicon atom | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [Silicon Dioxide results in increased abundance of Silicon] which results in increased expression of LGALS3 protein more ... | CTD | PMID:39353502 |
Lgals3 | Mouse | silicon atom | multiple interactions | EXP | | 6480464 | [Silicon Dioxide results in increased abundance of Silicon] which results in increased expression of LGALS3 protein | CTD | PMID:39353502 |
Lgals3 | Mouse | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of LGALS3 mRNA and Silicon Dioxide results in increased expression of LGALS3 protein | CTD | PMID:23221170 more ... |
Lgals3 | Mouse | silicon dioxide | multiple interactions | EXP | | 6480464 | [Silicon Dioxide results in increased abundance of Silicon] which results in increased expression of LGALS3 protein | CTD | PMID:39353502 |
Lgals3 | Mouse | silicon dioxide | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Silicon Dioxide results in increased expression of LGALS3 protein | CTD | PMID:36223831 |
Lgals3 | Mouse | silicon dioxide | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [Silicon Dioxide results in increased abundance of Silicon] which results in increased expression of LGALS3 protein more ... | CTD | PMID:39353502 |
Lgals3 | Mouse | silicon dioxide | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Silicon Dioxide results in increased expression of LGALS3 mRNA | CTD | PMID:21602193 and PMID:22431001 |
Lgals3 | Mouse | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of LGALS3 protein | CTD | PMID:29044176 |
Lgals3 | Mouse | sodium chloride | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [Sodium Chloride co-treated with Furaldehyde] results in decreased expression of and affects the localization of LGALS3 protein more ... | CTD | PMID:38598786 |
Lgals3 | Mouse | sodium dichromate | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | sodium bichromate results in increased expression of LGALS3 mRNA | CTD | PMID:25993096 |
Lgals3 | Mouse | sodium fluoride | decreases expression | EXP | | 6480464 | Sodium Fluoride results in decreased expression of LGALS3 protein | CTD | PMID:28918527 |
Lgals3 | Mouse | streptozocin | multiple interactions | ISO | Lgals3 (Rattus norvegicus) | 6480464 | [resveratrol co-treated with Streptozocin] results in increased expression of LGALS3 mRNA and vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LGALS3 mRNA] | CTD | PMID:16684804 and PMID:25905778 |
Lgals3 | Mouse | streptozocin | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Streptozocin results in increased expression of LGALS3 mRNA | CTD | PMID:16684804 |
Lgals3 | Mouse | sulindac | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | Sulindac inhibits the reaction [CDKN1A protein results in increased expression of LGALS3 mRNA] | CTD | PMID:15190207 |
Lgals3 | Mouse | sunitinib | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of LGALS3 mRNA | CTD | PMID:31533062 |
Lgals3 | Mouse | tamoxifen | affects expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Tamoxifen affects the expression of LGALS3 mRNA | CTD | PMID:14699072 |
Lgals3 | Mouse | temozolomide | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of LGALS3 mRNA | CTD | PMID:31758290 |
Lgals3 | Mouse | testosterone | decreases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Testosterone results in decreased expression of LGALS3 mRNA | CTD | PMID:33359661 |
Lgals3 | Mouse | testosterone | increases expression | EXP | | 6480464 | Testosterone deficiency results in increased expression of LGALS3 mRNA | CTD | PMID:33848595 |
Lgals3 | Mouse | tetrachloromethane | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of LGALS3 mRNA and Carbon Tetrachloride results in increased expression of LGALS3 protein | CTD | PMID:12629582 more ... |
Lgals3 | Mouse | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of LGALS3 protein | CTD | PMID:29044176 |
Lgals3 | Mouse | tetrachloromethane | multiple interactions | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride promotes the reaction [PURB protein binds to LGALS3 promoter] and schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of LGALS3 mRNA] | CTD | PMID:16309856 and PMID:31150632 |
Lgals3 | Mouse | tetrachloromethane | affects expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride affects the expression of LGALS3 mRNA | CTD | PMID:12734012 |
Lgals3 | Mouse | tetrachloromethane | multiple interactions | EXP | | 6480464 | LGALS3 gene mutant form inhibits the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] more ... | CTD | PMID:16549783 and PMID:23798564 |
Lgals3 | Mouse | tetrachloromethane | affects expression | EXP | | 6480464 | Carbon Tetrachloride affects the expression of LGALS3 mRNA | CTD | PMID:17484886 |
Lgals3 | Mouse | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of LGALS3 mRNA and Carbon Tetrachloride results in increased expression of LGALS3 protein | CTD | PMID:16549783 more ... |
Lgals3 | Mouse | tetracycline | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Tetracycline results in increased expression of LGALS3 mRNA | CTD | PMID:17522070 |
Lgals3 | Mouse | theophylline | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Theophylline results in increased expression of LGALS3 mRNA | CTD | PMID:17522070 |
Lgals3 | Mouse | thioacetamide | multiple interactions | EXP | | 6480464 | MGAT5 protein affects the reaction [Thioacetamide results in increased expression of LGALS3 mRNA] | CTD | PMID:23798564 |
Lgals3 | Mouse | thioacetamide | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of LGALS3 mRNA | CTD | PMID:34492290 |
Lgals3 | Mouse | thioacetamide | multiple interactions | ISO | Lgals3 (Rattus norvegicus) | 6480464 | [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of LGALS3 mRNA | CTD | PMID:28943392 |
Lgals3 | Mouse | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of LGALS3 mRNA | CTD | PMID:23798564 |
Lgals3 | Mouse | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of LGALS3 mRNA | CTD | PMID:23557971 and PMID:27760801 |
Lgals3 | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of LGALS3 gene | CTD | PMID:35295148 |
Lgals3 | Mouse | tremolite asbestos | increases expression | EXP | | 6480464 | tremolite results in increased expression of LGALS3 mRNA | CTD | PMID:29279043 |
Lgals3 | Mouse | trichloroethene | increases methylation | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased methylation of LGALS3 gene | CTD | PMID:27618143 |
Lgals3 | Mouse | trichostatin A | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of LGALS3 mRNA | CTD | PMID:24935251 and PMID:26272509 |
Lgals3 | Mouse | trichostatin A | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA | CTD | PMID:27188386 |
Lgals3 | Mouse | triclosan | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Triclosan results in increased expression of LGALS3 mRNA | CTD | PMID:30510588 |
Lgals3 | Mouse | triphenyl phosphate | affects expression | ISO | LGALS3 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of LGALS3 mRNA | CTD | PMID:37042841 |
Lgals3 | Mouse | tris(2-butoxyethyl) phosphate | affects expression | ISO | LGALS3 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of LGALS3 mRNA | CTD | PMID:29024780 |
Lgals3 | Mouse | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of LGALS3 mRNA | CTD | PMID:30912803 |
Lgals3 | Mouse | tunicamycin | increases expression | EXP | | 6480464 | Tunicamycin results in increased expression of LGALS3 mRNA | CTD | PMID:17127020 |
Lgals3 | Mouse | valdecoxib | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | valdecoxib results in increased expression of LGALS3 mRNA | CTD | PMID:24136188 |
Lgals3 | Mouse | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of LGALS3 mRNA | CTD | PMID:17963808 |
Lgals3 | Mouse | valproic acid | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA | CTD | PMID:27188386 |
Lgals3 | Mouse | valproic acid | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of LGALS3 mRNA | CTD | PMID:19101580 more ... |
Lgals3 | Mouse | valproic acid | affects expression | ISO | LGALS3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of LGALS3 mRNA | CTD | PMID:25979313 |
Lgals3 | Mouse | vanadyl sulfate | multiple interactions | ISO | Lgals3 (Rattus norvegicus) | 6480464 | vanadyl sulfate inhibits the reaction [Streptozocin results in increased expression of LGALS3 mRNA] | CTD | PMID:16684804 |
Lgals3 | Mouse | vancomycin | decreases expression | EXP | | 6480464 | Vancomycin results in decreased expression of LGALS3 mRNA | CTD | PMID:18930951 |
Lgals3 | Mouse | vinclozolin | affects expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | vinclozolin affects the expression of LGALS3 mRNA | CTD | PMID:19015723 |
Lgals3 | Mouse | vinclozolin | increases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | vinclozolin results in increased expression of LGALS3 mRNA | CTD | PMID:23034163 |
Lgals3 | Mouse | vorinostat | increases expression | ISO | LGALS3 (Homo sapiens) | 6480464 | vorinostat results in increased expression of LGALS3 mRNA | CTD | PMID:26272509 |
Lgals3 | Mouse | vorinostat | multiple interactions | ISO | LGALS3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of LGALS3 mRNA | CTD | PMID:27188386 |
Lgals3 | Mouse | zinc oxide | decreases expression | ISO | Lgals3 (Rattus norvegicus) | 6480464 | Zinc Oxide results in decreased expression of LGALS3 protein | CTD | PMID:33205376 |